2013 International Conference on Diabetes and Metabolism

> Home > Scientific program

CD2 Pleiotrophic effects of incretins (AASD)

Thursday, 7 November 10:20~11:50 / Convention hall B
Chair: Ho Young Son


	Young Min Cho Seoul National University, Korea		CD2-1 GLP-1 and cardiovascular system
	Dae Ho Lee Wonkwang University, Korea		CD2-2 Non-glycemic effect of DPP4/CD26
	Norio Harada Kyoto University, Japan		CD2-3 GIP and high-fat diet-induced obesity

CD4 Gestational diabetes update (ICDM)

Thursday, 7 November 16:00~17:30 / Convention hall B
Chair: Hak Chul Jang


	Catherine Kim University of Michigan, USA		CD4-1 Adopting of IADPSG criteria for GDM in U.S.
	Soo-Heon Kwak Seoul National University, Korea		CD4-2 Searching MODY genetic variants in GDM women
	Sun Min Kim Seoul National University, Korea		CD4-3 Prediction and risk assessment of gestational diabetes

CD6 Clinical Diabetes (Committee of clinical practice guideline) (ICDM)

Friday, 8 November 09:00~10:30 / Convention hall B
Chair: Yu-Bae Ahn


	William C. Knowler NIH, USA		CD6-1 Should we treat pre-diabetes?
	Dong Jun Kim Inje University, Korea		CD6-2 Clinical characteristics of impaired fasting glucose in Korea
	Chul-Hee Kim Soonchunhyang University, Korea		CD6-3 Update of KDA clinical practice guideline on drug treatment for type 2 diabetes (Public hearing)

CD9 Providing optimal treatment for type 1 diabetes (ICDM)

Saturday, 9 November 09:00~10:30 / Convention hall B
Chair: Kwang-Won Kim


	Harold David McIntyre The University of Queensland, Australia		CD9-1 Dose adjustment for normal eating (DAFNE) in the treatment of type 1 diabetes: promoting the ‘expert patient’
	Seung Yang Hallym University, Korea		CD9-2 How to provide optimal treatment for Korean children and adolescents with type 1 diabetes
	Jae Hyeon Kim Sungkyunkwan University, Korea		CD9-3 Where are we, what still needs to be done in the management of Korean adults with type 1 diabetes?